Taken together, this study shows that the interference of E6-mediated p53 degradation can be achieved with the medicinal plant compound that promotes cancer cell death in HPV-induced malignant cells and, accordingly, signifies a possible alternative medicinal treatment for HPV-associated epithelial cancers. The gene discussed is TP53; the disease is cancer.